MSH6 and colorectal cancer: The cumulative colorectal cancer incidence in males was significantly higher than that in females in MLH1-mutated patients (P = 0.02) (Fig 2), while there were no significant differences in MSH2- and MSH6-mutated LS patients (P = 0.70 and P = 1.00, respectively).